References

EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units

10.1001/jama.2009.1754 · 2009 · External reference

Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis

10.1016/s0140-6736(10)61458-4 · 2011 · External reference

EPIC III Investigators. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017

10.1001/jama.2020.2717 · 2020 · External reference

ICON investigators. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit

10.1016/s2213-2600(14)70061-x · 2014 · External reference

Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system

10.1001/jamainternmed.2013.9763 · 2013 · External reference

Clinical and economic impact of ventilator-associated pneumonia in intensive care units in Japan

2025 · External reference

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

10.1016/s0140-6736(21)02724-0 · 2022 · External reference

Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

10.1016/s1473-3099(18)30605-4 · 2019 · External reference

An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation

10.1016/j.jclinepi.2008.02.008 · 2008 · External reference

Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models

10.1186/cc6852 · 2008 · External reference

Unresolved reference

External reference

Outcomerea Study Group. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis

10.1164/rccm.201105-0867oc · 2011 · External reference

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

10.1097/01.ccm.0000217961.75225.e9 · 2006 · External reference

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

10.1128/aac.01509-06 · 2007 · External reference

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study

10.1016/s1473-3099(10)70258-9 · 2011 · External reference

Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study

10.1371/journal.pone.0233265 · 2020 · External reference

Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal

10.1017/ice.2021.429 · 2022 · External reference

Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance

10.1007/s00134-017-5036-1 · 2018 · External reference

Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis

10.3390/antibiotics9020096 · 2020 · External reference

Patient-level cost analysis of intensive care unit-acquired infections: a prospective cohort study

10.1016/j.jhin.2024.07.002 · 2025 · External reference

Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis

10.1371/journal.pone.0227139 · 2020 · External reference